Jack Anders Revolution Medicines, Inc. (RVMD) insider trading activity

Jack Anders is Chief Financial Officer of Revolution Medicines, Inc.. Currently has a direct ownership of 101,959 shares of RVMD, which is worth approximately $4.02 Million. The most recent transaction as insider was on May 03, 2024, when has been sold 10,000 shares (Common Stock) at a price of $40.03 per share, resulting in proceeds of $400,300. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 102K

33.43% 3M change

84.6% 12M change

Total Value Held $4.02 Million

Jack Anders Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 03 2024	SELL Open market or private sale	$400,300 $40.03 p/Share	10,000 Reduced 8.93%	101,959 Common Stock
May 03 2024	BUY Exercise of conversion of derivative security	$26,800 $2.68 p/Share	10,000 Added 8.2%	111,959 Common Stock
Mar 18 2024	SELL Open market or private sale	$39,822 $31.58 p/Share	1,261 Reduced 1.22%	101,959 Common Stock
Mar 01 2024	BUY Grant, award, or other acquisition	-	26,400 Added 20.37%	103,220 Common Stock
Dec 18 2023	SELL Open market or private sale	$45,972 $25.9 p/Share	1,775 Reduced 2.27%	76,416 Common Stock
Oct 23 2023	BUY Exercise of conversion of derivative security	$83,136 $3.39 p/Share	24,524 Added 23.88%	78,191 Common Stock
Sep 18 2023	SELL Open market or private sale	$44,679 $31.31 p/Share	1,427 Reduced 2.59%	53,667 Common Stock

Sep 01 2023	SELL Open market or private sale	$701,000 $35.05 p/Share	20,000 Reduced 26.63%	55,094 Common Stock
Sep 01 2023	BUY Exercise of conversion of derivative security	$53,600 $2.68 p/Share	20,000 Added 21.03%	75,094 Common Stock
Jun 20 2023	SELL Open market or private sale	$31,087 $24.89 p/Share	1,249 Reduced 2.22%	55,094 Common Stock
Mar 17 2023	SELL Open market or private sale	$14,483 $21.78 p/Share	665 Reduced 1.19%	55,233 Common Stock
Mar 01 2023	BUY Grant, award, or other acquisition	-	26,600 Added 32.24%	55,898 Common Stock
Dec 19 2022	SELL Open market or private sale	$15,094 $22.94 p/Share	658 Reduced 2.2%	29,298 Common Stock
Sep 19 2022	SELL Open market or private sale	$8,549 $19.04 p/Share	449 Reduced 1.48%	29,956 Common Stock
Sep 01 2022	BUY Grant, award, or other acquisition	-	10,000 Added 24.75%	30,405 Common Stock
Jun 17 2022	SELL Open market or private sale	$7,206 $17.75 p/Share	406 Reduced 1.95%	20,405 Common Stock
Mar 17 2022	SELL Open market or private sale	$2,961 $18.62 p/Share	159 Reduced 0.79%	19,875 Common Stock
Mar 01 2022	BUY Grant, award, or other acquisition	-	11,600 Added 36.67%	20,034 Common Stock
Dec 17 2021	SELL Open market or private sale	$4,150 $24.41 p/Share	170 Reduced 1.98%	8,434 Common Stock
Sep 17 2021	SELL Open market or private sale	$4,983 $30.02 p/Share	166 Reduced 1.99%	8,192 Common Stock
Jun 17 2021	SELL Open market or private sale	$5,459 $34.12 p/Share	160 Reduced 1.88%	8,358 Common Stock
Mar 04 2021	BUY Grant, award, or other acquisition	-	7,400 Added 48.35%	7,904 Common Stock
Oct 13 2020	SELL Open market or private sale	$440,000 $44.0 p/Share	10,000 Reduced 100.0%	0 Common Stock
Oct 13 2020	BUY Exercise of conversion of derivative security	$26,800 $2.68 p/Share	10,000 Added 50.0%	10,000 Common Stock
Oct 06 2020	SELL Open market or private sale	$400,000 $40.0 p/Share	10,000 Reduced 100.0%	0 Common Stock

Jack Anders

Chief Financial Officer

Redwood City, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RVMD shares.

Notify only if

Value

Insider Trading

Get notified when an Revolution Medicines, Inc. insider buys or sells RVMD shares.

Notify only if

Operation

Value

Type

News

Receive news related to Revolution Medicines, Inc.

Track Activities on RVMD

Account